Isomorphic Labs
Isomorphic Labs is an AI-first drug design and development company leveraging the power of AI to accelerate drug discovery and bring new treatments to patients. The company uses its AI drug design engine to advance drug design programs across multiple therapeutic areas and drug modalities, focusing on biomedical breakthroughs.
Funding Round: Series A
Funding Amount: $600M
Date: 31-Mar-2025
Investors: Thrive Capital, GV, Alphabet
Markets: AI, Biotech, Pharmaceuticals
HQ: London, England, United Kingdom
Founded: 2021
Website: https://www.isomorphiclabs.com/
LinkedIn: https://www.linkedin.com/company/isomorphic-labs
Twitter: https://x.com/IsomorphicLabs
Crunchbase: https://www.crunchbase.com/organization/isomorphic-labs
Leave a Comment
Comments
No comments yet.